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Gut microbiome comparability 
of fresh-frozen versus stabilized-
frozen samples from hospitalized 
patients using 16S rRNA gene and 
shotgun metagenomic sequencing
emma e. ilett1, Mette Jørgensen1, Marc noguera-Julian  2, Gedske Daugaard3, 
Daniel D. Murray1, Marie Helleberg1, Roger paredes  2,4, Jens Lundgren1, Henrik Sengeløv5 & 
cameron Macpherson1
Collection of faecal samples for microbiome analysis in acutely sick patients is logistically difficult, 
particularly if immediate freezing is required (i.e. fresh-frozen, or FF sampling). previous studies in 
healthy/non-hospitalized volunteers have shown that chemical stabilization (i.e. stabilized-frozen, or 
SF sampling) allows room-temperature storage with comparable results to FF samples. to test this in 
a hospital setting we compared FF and SF approaches across 17 patients undergoing haematopoietic 
stem cell transplantation (HSCT) using both 16S rRNA gene and shotgun metagenomic sequencing. A 
paired (same stool specimen) comparison of FF and SF samples was made, with an overall comparable 
level in relative taxonomic abundances between the two sampling techniques. though shotgun 
metagenomic sequencing found significant differences for certain bacterial genera (P < 0.001), these 
were considered minor methodological effects. Within-sample diversity of either method was not 
significantly different (Shannon diversity P16SrRNA = 0.68 and Pshotgun = 0.89) and we could not reject 
the null hypothesis that between-sample variation in FF and SF were equivalent (P16SrRNA = 0.98 and 
Pshotgun = 1.0). This indicates that SF samples can be used to reliably study the microbiome in acutely 
sick patient populations, thus creating and enabling further outcomes-based metagenomic studies on 
similarly valuable cohorts.
It is becoming increasingly clear that analysis of the human gut microbiome can reveal critical aspects of human 
disease pathogenesis, as well as the variation of treatment responses among a variety of patient groups1–3. As a 
result, a growing number of hospitals are trying to establish clinical biobanks of stool samples for use in down-
stream research projects.
Currently, the considered “gold standard” for microbiome studies suggests that stool samples be collected 
and then undergo immediate DNA-extraction or at least immediate freezing at −20/−80 °C. However, it is very 
difficult to comply with these conditions in a hospital setting, where even refrigeration of samples is difficult due 
to limited resources, irregular sampling time-points or patient visits, as well as the need to prioritize patient care. 
Additionally, complete capture and follow-up of many patient populations would require at-home sampling of 
out-patients, adding further variability to the time between sampling and freezing. Therefore, the ideal sample 
collection method within hospitals would rather allow for samples to be kept at room temperature prior to freez-
ing. This would enable at-home sample collection for out-patients, no need for urgent hospital carriers for sample 
delivery, and no requirement for same-day DNA-extraction.
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Although chemical stabilization followed by a delayed time to freezing (stabilized-frozen freeze (stable-freeze, 
or SF) appears to be a good alternative to direct freezing (fresh-freeze, or FF) or fresh DNA-extraction 
(fresh-extract, or FE), all studies to date assessing its use are based on cohorts of non-hospitalized/healthy volun-
teers4–22. In particular, there is an open question as to the use of SF protocols when microbiomes are expected to 
have low diversity8. It is therefore currently uncertain whether or not results from previous method studies can be 
applied to samples collected in a hospital, where low diversity gut microbiomes are likely. Additionally, there have 
been little data evaluating the effect of SF methods using shotgun metagenomic sequencing4,7,14, which, unlike 
16S rRNA gene sequencing data, provides detailed species level information. As bacterial species can differ in 
diseased populations, it is essential to collect this information and evaluate whether SF affects their compositions 
or not.
To address these remaining aspects of collection-associated bias within gut microbiomes of the diseased, 
we have conducted a study comparing FF samples to those collected using a SF protocol. This is the first study 
(to our knowledge) assessing the differences between these protocols using both 16S rRNA gene and shotgun 
metagenomic sequencing in a hospital setting. Our study was performed in a cohort of patients undergoing hae-
matopoietic stem cell transplantation (HSCT) at Rigshospitalet, University of Copenhagen, Denmark. Samples 
were delivered to the Centre of Excellence for Personalised Medicine for Infectious Complications in Immune 
Deficiency (PERSIMUNE)23 biobank, also located at Rigshospitalet. HSCT serves as a useful disease proxy as it is 
reserved for severely diseased patients and, critically, has been shown to heavily impact microbiome structure24.
Results
A total of 26 paired stool samples were generated from 17 haematology patients undergoing myeloablative or 
non-myeloablative HSCT. Each stool sample pair consisted of 1 FF sample (i.e. freshly frozen at time of sampling), 
and 1 SF sample (i.e. chemically stabilized prior to freezing after a variable period no greater than 16 days). An 
overview of the study design, summarized baseline patient and sample information, as well as time from sampling 
to freezing can be found in Fig. 1. Specific patient/sample numbers with time from HSCT to sampling and freez-
ing can be found in Supplementary Table S1.
Data quality. To ensure that data from both sampling methods were acceptable for analysis, all samples 
underwent quality control steps as described in the methods section.
Figure 1. (a) Overview of study design with general patient and sample information. FF = Fresh-frozen, 
SF = Stabilized-frozen. (b) Overview of the bioinformatic pipeline. (c) Overview of calendar time from sample 
collection to freezing for all FF (fresh-frozen) and SF (stabilized-frozen) samples. Arrows indicate if pre-HSCT 
or post-HSCT samples.
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16S rRNA gene sequencing data. One sample was removed due to a severe lack of overlap between paired-ends 
(a fundamental requirement of our analysis pipeline). Another sample was lost due to low sequence content 
(<10,000 unfiltered reads). We observed a minor batch effect across sample runs that slightly biased mean quality 
and read numbers by affecting reverse-end sequences. However, our pipeline largely removed this bias by merg-
ing paired ends and filtering (see Methods). All filtered samples had mean quality scores of over 34 with >10,000 
reads and batch effects did not influence which samples passed quality control steps. To summarize, high quality 
data was collected for 24 of the 26 stool samples.
Shotgun metagenomic sequencing data. Seven samples were removed as their sequenced data did not contain 
sufficient information for further study, either due to poor quality, human contamination, or sequencing issues 
(threshold of 1 million reads). All samples had final mean quality scores of over 37 with > 3.5 million reads. To 
summarize, high quality data was collected for 21 of the 26 stool samples, resulting in a paired sample overlap of 
76% (i.e. 76% of paired samples had both 16S rRNA gene and shotgun metagenomic sequencing data after quality 
control steps). The other 24% of samples had either 16S rRNA gene or shotgun metagenomic sequencing data 
available for analysis.
Alpha-diversity. We next assessed possible differences between methods for within-sample diversity (i.e. 
alpha-diversity).
16S rRNA gene sequencing data. We found a general increase of observed genera in the SF versus FF samples. 
However, this was not significant (Wilcoxon paired test, P = 0.11) and other alpha diversity measures showed 
no differences (Fig. 2a). The mean Simpson index was 0.78 (IQR 0.68-0.88) vs 0.77 (IQR 0.67-0.87) in FF and 
SF samples respectively. Similarly, the mean Shannon indices were likewise comparable at 2.30 (IQR 1.82-2.69) vs 
2.25 (IQR 1.80-2.69) in FF and SF samples respectively. Indeed, there was no statistically significant difference in 
either alpha diversity measure (Wilcoxon paired test, PSimpson = 0.81 and PShannon = 0.68).
Shotgun metagenomic sequencing data. As with 16S rRNA gene sequencing, the mean Simpson and Shannon 
indices were similar between FF and SF samples at 0.50 (IQR 0.13-0.74) vs 0.51 (IQR 0.43-0.70) and 1.15 (IQR 
0.38-1.61) vs 1.16 (IQR 0.72-1.55), respectively (Fig. 2b). As expected from the IQRs there was no significant 
difference in either diversity measure (Wilcoxon paired test, PSimpson = 0.73 and PShannon = 0.89).
Shotgun metagenomics gene richness. As an additional measure to assess diversity we also examined gene rich-
ness (the number of unique genes) in the shotgun metagenomic sequencing data. This measure is used to divide 
samples into those of low versus high gene richness, with those of high gene richness generally considered to have 
higher diversity.
There was a median of 5,507,430 reads per sample mapping to the IGC (Integrated Gene Catalogue)25 (inter-
quartile range (IQR) 4,460,836–6,047,576). Based on a rarefaction curve of mapped reads and the number of 
unique genes (Supplementary Fig. S1), samples with <5 million mapped reads were discarded for the gene rich-
ness analysis as their diversity was biased by sampling. The 12 remaining sample pairs had a median of 47,180 
unique genes per sample (IQR 34,876–69,799). FF and SF samples had similar medians of 49,086 and 44,004, 
respectively (Fig. 3). There was no evidence of a statistically significant difference in gene richness between FF 
and SF samples (Wilcoxon paired test, P = 0.91). Two paired samples are notable for their unusually high gene 
richness (Fig. 3).
Beta-diversity. We next assessed the beta-diversity, or between-sample diversity, looking for changes in var-
iance between paired samples and testing whether potential differences were driven by sampling method.
16S rRNA gene sequencing data. A non-metric multidimensional scaling (NMDS) plot based on Bray-Curtis 
distances showed a strong overlap of sampling method types and clustering of sample pairs (Fig. 4a). An ADONIS 
test on the Bray-Curtis distances showed no evidence of differences between SF and FF samples (P = 1.00).
Shotgun metagenomic sequencing data. As with the 16S rRNA gene sequencing data, the NMDS plot showed 
a strong overlap of sampling methods and clustering of sample pairs (Fig. 4b). The ADONIS again showed no 
evidence of differences between samples being based on sampling method (P = 0.67).
Taxonomy and relative abundance. To look more specifically at possible compositional differences, i.e. if certain 
bacteria were affected by sampling methods, we compared taxonomical differences between FF and SF samples 
by calculating the relative abundances of their genera.
16S rRNA gene sequencing data. Relative abundances of genera between FF and SF sample pairs appeared vis-
ually similar when examining bacteria present in the sample cohort (Fig. 5). This was verified statistically by 
paired DESeq2 analysis, which found no significant difference (α = 5%) in the relative abundances of all genera 
between FF and SF methods.
Shotgun metagenomic sequencing. As with the 16S rRNA gene sequencing data, relative abundances of gen-
era were visually similar (Fig. 5) but the Wald test of paired DESeq2 highlighted statistically significant differ-
ences between FF and SF in the relative abundance of 7 genera (Actinomyces, Brevibacterium, Cryptobacterium, 
Propionibacteriaceae (unclassified), Propionibacterium, Ralstonia, Ruminococcus, P < 0.001 for all). These differ-
ences were, however, found in a maximum of 3/21 sample pairs per bacterial genus, with all but one sample pair 
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having differences in abundancy of < 3% (Supplementary Fig. S2). This highlights the sensitivity and reproduci-
bility of shotgun-based sequencing, but also demonstrates the lack of consistent or predictable change one would 
expect if driven by sampling methodology.
Figure 2. (a) Alpha diversity measures based on 16S rRNA gene data for each sampling method, with pairs 
connected by lines. Circle vs triangle shapes represent pre-HSCT vs post-HSCT samples respectively. There was 
no statistically significant difference between fresh-frozen (FF) and stabilized-frozen (SF) samples regarding 
the number of observed species, Shannon or Simpson indexes. (b) Alpha diversity measures based on shotgun 
metagenomic data for each sampling method, with pairs connected by lines. Circle vs triangle shapes represent 
pre-HSCT vs post-HSCT samples respectively. There was no statistically significant difference between fresh-
frozen (FF) and stabilized-frozen (SF) samples regarding the number of observed species, Shannon or Simpson 
indexes. These figures have been created with help of the R(v3.5.0)29/PhyloSeq37 package.
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Discussion
In our study we show that SF is comparable to FF protocols in a diseased and hospitalized cohort using both 16S 
rRNA gene and shotgun metagenomic sequencing data. When comparing the alpha-diversity between sampling 
methods we found no significant difference between SF and FF samples. Differences between samples (based 
on Bray-Curtis distances) in our study were not driven by the different sampling methods. Both findings are in 
agreement with the current literature based on healthy cohorts5–9,16,22.
One concern with the use of chemical stabilization was the introduction of biases with regard to changes in the 
relative abundance of certain bacteria. Two studies using 16S rRNA gene sequencing found a significant increase 
in the Sutterella genus in SF versus FF samples5,9. While another study found significant differences in the relative 
abundances of Faecalibacterium, Sporobacter, Clostridium XVIII, and Clostridium XIVa, with differences being 
exacerbated in samples of low diversity8. However, we found no difference in the relative abundance of these or 
any other bacteria in our 16S rRNA gene sequencing analysis. In our shotgun metagenomic analysis there were 
minor differences in several bacteria driven only by a few sample pairs. This shows that differences in taxonomical 
abundance between methods are inconsistent across studies and may be due to background noise. Additionally, in 
the case of Hill et al., differences could also stem from comparing the SF protocol with directly processed samples 
(i.e. direct DNA extraction prior to freezing). Moreover, previous studies in healthy subjects support our conclu-
sion being that there is little difference between SF and FF methods5–7,14–16,18.
Limitations to our study may include the non-homogenisation of samples. It has been shown that sampling 
from different parts of a stool can give different microbial compositional results20. However, stool sampling 
is random and therefore the paired design of our study should control for the non-homogenisation. Another 
potential limitation to our study is the fact that a number of FF samples were not frozen directly (Fig. 1c and 
Supplementary Table S1). However, all of these samples were kept at 4 °C until frozen. Previous studies have 
shown that cold storage can preserve microbial composition for a short period of time and up to 1 week6,8,9,26,27. 
This difficulty in direct freezing highlights the need for methodologies that allow for more flexibility between 
sampling and freezing, as immediate freezing is not always possible in a hospital setting. Finally, there was a 
slight batch effect in our 16S rRNA gene sequencing data due to an uneven distribution of FF versus SF samples 
in sequencing runs. This mainly affected reverse-end sequence quality and related variance between batches 
was minimized during processing. All reads went through the same quality control process, as described in our 
methods and results, and there were no observed microbial compositional differences between samples run on 
different batches. Importantly, batch-free shotgun metagenomic data yielded markedly similar results to the 16S 
rRNA gene sequencing data.
In conclusion, chemical stabilization (SF) proved to be comparable to freshly frozen (FF) stool samples in 
a diseased, low microbial diversity, cohort. We confirmed this by statistical examination of measurements by 
two independent high-throughput sequencing technologies, namely 16S rRNA gene and shotgun metagenomic 
sequencing. We further showed that use of stabilization techniques maintains reproducibility in cross-sectional 
studies by minimizing technical variance in sample handling. Our results support the use of chemical stabiliza-
tion to increase the feasibility of hospital biobank stool sample collection, which will help facilitate the collection 
of longitudinal faecal microbiome samples from diseased patient groups.
Figure 3. Gene richness (i.e. the number of unique genes) for each sample per method and connected as 
sample pairs. Circle vs triangle shapes represent pre-HSCT vs post-HSCT samples respectively. Box plots show 
interquartile ranges (minimum and maximum values as whiskers) for gene richness per sampling method. A 
Wilcoxon paired test found no significant difference in the mean gene richness between fresh-frozen (FF) and 
stabilized-frozen (SF) samples. This figure has been created with help of the R(v3.5.0)29/PhyloSeq37 package.
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Methods
Sample collection. Two samples (i.e. aliquots) were taken from each stool by the patient or nursing staff at 
the same time-point. The EasySampler® Stool Collection Kit was used to hold the stool above toilet water during 
collection. If patients were bedridden, samples were collected directly from stool in bedpans. No stool was stored 
prior to sampling (i.e. sampling was done directly after defecation) and stool material was not homogenised. FF 
samples were placed in a non-sterile tube without stabilization fluid and delivered to the PERSIMUNE biobank 
by urgent hospital carrier and frozen directly during regular working hours (i.e. Monday-Friday, 8am-3pm). If 
outside of regular working hours, the FF sample would still be delivered to the biobank by urgent hospital carrier 
but then placed in the biobank refrigerator at 4 °C until regular working hours when it would then be frozen. SF 
samples were placed in the OMNIgene.GUT tube (containing stabilization fluid) according to the manufactur-
er’s instructions and delivered to the PERSIMUNE biobank by non-urgent hospital carrier. Non-urgent hospital 
carrier meant that samples could be kept at room temperature for up to several days prior to freezing. Due to the 
need for swift delivery of FF samples, no samples were taken at patients’ homes, i.e. all stool was collected at the 
hospital.
All samples were handled by personnel at the PERSIMUNE biobank. Half of the SF samples (n = 13) were 
further aliquoted into two sterile tubes prior to freezing, whereas remaining SF samples and all FF samples were 
frozen directly without further aliquoting. All samples were frozen at −80 °C.
Figure 4. (a) 16S rRNA gene sequencing data of beta diversity using Bray-Curtis distances to compare 
sampling methods represented in a NMDS plot. Sampling pairs are connected by lines with circle vs triangle 
shapes representing pre-HSCT vs post-HSCT samples respectively. FF = Fresh-frozen, SF = Stabilized-frozen. 
(b) Shotgun metagenomic sequencing data of beta diversity using Bray-Curtis distances to compare sampling 
methods represented in a NMDS plot. Sampling pairs are connected by lines with circle vs triangle shapes 
showing sampling time relative to HSCT. FF = Fresh-frozen, SF = Stabilized-frozen. These figures have been 
created with help of the R(v3.5.0)29/PhyloSeq37 package.
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The OMNIgene.GUT (DNA Stabilized-frozen Inc., Ottawa, Canada) stabilisation tube was chosen as the best 
candidate for our SF protocol. No commercial influence on this decision was allowed, i.e. this decision was not 
made to promote a specific brand, we did not consult with marketing holders, and did not receive financial sup-
port. The decision was based on a review of available documentation and literature: OMNIgene.GUT was found 
to have the least effect on gut microbiome composition compared to other stabilization fluids9, with results gen-
erally being comparable to FF samples5,8,15 and differences among sampling methods being of a lower scale than 
those between individuals6,8,16. The OMNIgene.GUT stabilisation tube should allow samples to be kept at room 
temperature for up to 60 days (according to manufacturer guidelines) and a previous study (based on a healthy 
cohort) has shown that the OMNIgene.GUT collection kit gave similar results after 28 days at room temperature 
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Figure 5. Shotgun metagenomic and16S rRNA gene sequencing data identifying the bacterial genera and 
species found in the sample cohort and their relative abundances (in percent) present in each individual sample. 
“Other” are identified bacteria that are not in the top 30 found genera and species respectively across the cohort. 
“Unidentified” represent bacteria that are among the top 30 genera/species but are unidentifiable at that level. 
All top 30 bacterial species and genera are represented by a colour shown in the figure key. These colours are 
displayed as either a square or triangle: (square) evidence found at genus level, colours only map to genus 
panels; and (triangle) evidence found for species, colours map to both genus and species panels. There are more 
than 30 species/genera due to the different taxonomies used for 16S rRNA gene and shotgun metagenomic 
sequencing analysis. This figure has been created with help of the R(v3.5.0)29/PhyloSeq37 package. For specific 
values of all relative abundances used in this figure (i.e. the top 30 genera/species from all samples) please see 
Supplementary Table S2).
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as samples with freshly-extracted DNA7. For additional information regarding the stabilizer decision process, and 
an overview of stabilization comparison studies please see Supplementary Methods.
Sample shipment. All samples (26 FF and 26 SF, i.e. 52 paired samples) were transported on dry ice to the 
IrsiCaixa AIDS Research Institute in Spain for 16S rRNA gene and shotgun metagenomic sequencing.
DNA extraction. All samples were thawed on ice and DNA was extracted from ~200 mg of each faecal sam-
ple using the PowerSoil DNA Extraction Kit (MO BIO Laboratories, Carlsbad, CA, US). Extracted DNA was then 
stored at −80 °C until sequencing.
Library construction and sequencing. 16S rRNA gene sequencing. DNA was PCR amplified using 
primers for targeting regions flanking the variable regions V3-4 of the 16S rRNA gene (expected amplicon 
size ~460 base pairs). Primers were those described in the “MiSeq rRNA Amplicon Sequencing” protocol from 
Illumina, which already have the Illumina adapter overhang nucleotide sequences added to the 16S rRNA V3-V4 
specific-primers, i.e.: 16S_F 5′-(TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG CCT ACG GGN 
GGC WGC AG)-3′ and 16S_R 5′-(GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA CTA CHV 
GGG TAT CTA ATC C)-3′.
Amplifications were performed in triplicate 25 μL reactions, each containing 2.5 μL of non-diluted DNA 
template, 12.5 μL of KAPA HiFi HotStart Ready Mix (containing KAPA HiFi HotStart DNA Polymerase, buffer, 
MgCl2, and dNTPs, KAPA Biosystems Inc., Wilmington, MA, USA), and 5 μL of each primer at 1 μM. Thermal 
cycling conditions consisted of an initial denaturation step (3 min at 95 °C), followed by 30 cycles of denatura-
tion (30 sec at 95 °C), annealing (30 sec at 55 °C) and extension (30 sec at 72 °C). These were followed by a final 
extension step of 10 min at 72 °C. Once the desired amplicon was confirmed in 1% agarose gel electrophoresis, all 
three replicates were pooled and stored at −30 °C until sequencing library preparation. Amplified DNA templates 
were cleaned-up for non-DNA molecules and Illumina sequencing adapters and dual indices were attached using 
Nextera XT Index Kit (Illumina, Inc.) followed by the corresponding PCR amplification program as described in 
the MiSeq. 16S rRNA Amplicon Sequencing protocol. After a second round of clean-up, amplicons were quan-
tified using Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen, Carlsbad, MA, USA) and diluted in equimo-
lar concentrations (4 nM) for further pooling. Sequencing was performed on an Illumina MiSeqTM platform 
according to the manufacturer’s specifications to generate paired-end reads of 300 base-length in each direction. 
Samples were sequenced in two batches (not all sample pairs were sequenced in the same batch).
Shotgun metagenomic sequencing. Whole faecal DNA was chemically fragmented using the Nextera-XT® 
Illumina kit. One library of approximately 300-basepair-clone insert size was constructed for each sample. Total 
faecal DNA was sequenced in five runs on an Illumina Hi-Seq® platform at the Institut de Medicina Predictiva del 
Cancer (IMPPC), Badalona, Spain.
pre-processing and quality control. 16S rRNA gene sequencing data. The FastQC software28 and the 
R(v3.5.0)29/DADA230 plotQualityProfile was used to assess raw sequence quality. Primer trimming and read 
merging was performed using Cutadapt31 and PEAR (Illumina Paired-End reAd merger)32. Non-merging reads 
and those with unidentified primers were discarded. Resulting reads were put into the R(v3.5.0)29/DADA230 
pipeline and subsequently quality filtered and trimmed. Briefly, reads were trimmed by 6 nucleotides from the 
start of the read, all were truncated at the first nucleotide with a quality score of ≤5 (if there was one) and those 
with ≥2 expected errors in the read were discarded. Reads with <350 base pairs after filtering and trimming 
were removed. One million random filtered reads were used to create the error model in DADA230. Chimeric 
sequences were filtered off using a consensus approach. Samples with <10,000 read counts after processing were 
discarded. If one sample failed quality control the sample pair was removed from further analysis.
Shotgun metagenomic sequencing data. Specific adapters were removed using the Illumina HiSeq software and 
Trimmomatic33. Trimmomatic33 was also used for quality trimming (nucleotides were trimmed from the start 
or end of the read if they had a quality score <30, then using a sliding window approach, reads were cut if 
the average quality of 4 nucleotides was <30). Reads <50 base pairs were removed. Paired reads were mapped 
with bowtie234 to the human genome (GRCh38). All read pairs where one or both mates mapped to the human 
genome were discarded. Final read quality was assessed using the R package ShortRead35 and bowtie234 output 
files. Samples with <1 million reads were removed from further analysis. If one sample failed quality control the 
sample pair was removed from further analysis.
ethical approval. This study was conducted with approval from the Danish Ethical Committee 
(J.nr.H-16047481). All patients had given informed consent to the donation and storage of stool samples for 
microbial research. All methods were performed in accordance with the relevant guidelines and regulations.
taxonomy and diversity measures. 16S rRNA gene sequencing data. Taxonomy was assigned through 
alignment to the RDP (Ribosomal Database Project)36 using the R(v3.5.0)29/DADA230 program. Taxonomical 
annotation was used to remove all OTUs assigned as mitochondria or chloroplasts, all OTUs assigned a 
non-bacterial kingdom and all OTUs present in <2 samples. The filtered OTU table was used in the R(v3.5.0)29/
Phyloseq37 package to calculate relative abundances (at genus and species level), alpha diversity measures 
(Shannon and Simpson indexes) and beta diversity measures (Bray-Curtis dissimilarity; used as input for ordina-
tion analysis using non-metric multidimensional scaling (NMDS)). Specifically, relative abundances were based 
on OTU counts and were normalised as percentages (100 * (x/sum(x))) at species and genera taxonomy levels. 
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Alpha diversity measures were calculated based on OTU counts without prior normalisation. Beta diversity meas-
ures were calculated based on normalised (x/sum(x)) OTU counts.
Shotgun metagenomic sequencing data. Taxonomical annotation was assigned using MetaPhlAn v2.038. The rel-
ative proportions calculated from MetaPhlAn v2.038 on genus and/or species level were used to calculate relative 
abundances, alpha diversity measures (Shannon and Simpson indexes) and beta diversity measures (Bray-Curtis 
dissimilarity; used as input for ordination analysis using non-metric multidimensional scaling (NMDS)) in the 
R(v3.5.0)29/Phyloseq37 package. Relative abundances were calculated as percentages (i.e. relative proportions were 
multiplied by 100) at both species and genera taxonomy levels. Due to alpha diversity measures often being cal-
culated based on unnormalized data, we used the rounded fraction of the relative proportions of bacterial species 
from MetaPhlAn v2.038 (i.e. relative proportion * 10,000 rounded up to the closest integer) to calculate these 
measures. For beta diversity measures the relative proportion values of bacterial species could be used directly 
(i.e. values did not need to be re-normalised prior to calculation).
MetaPhlAn v2.038 also provided estimations of the number of reads that should come from a given species by 
considering the coverage of the species’ markers and the length of the genome (taken from reference genomes). 
Using the estimated number of reads per genera a count table was created for shotgun taxonomical data compat-
ible with the R(v3.5.0)29/PhyloSeq37 package. This count table, based on the estimation of reads from bacterial 
genera, was used for later DESeq239 analyses.
Gene richness was calculated using bowtie234 to map filtered reads to the IGC (Integrated Gene Catalogue)25. 
Based on a rarefaction curve of number of new unique genes and number of mapped reads (counting forward 
reads only), a cut-off of 5 million mapped reads was decided to calculate gene richness (Supplementary Fig. S1). 
Only forward reads were used to calculate the number of unique genes, with a maximum of 1 unique gene per 
read.
Statistical analysis. The following statistical analyses were performed for both 16S rRNA gene and shotgun 
metagenomic sequencing data. Detection of differentially abundant bacterial genera between methods was per-
formed using the R(v3.5.0)29/PhyloSeq37 and R(v3.5.0)29/DESeq239 packages. Using the Wald test in DESeq239, SF 
and FF methods were compared for potential statistical differences in their geometric means of bacterial genera. 
PERMANOVA (adonis) tests (via the R(v3.5.0)29/vegan package40) were also performed using Bray-Curtis dis-
tances to test for a potential association between sampling methods and microbiota composition. For all statistical 
analyses, P-values < 0.05 were considered significant.
16S rRNA gene sequencing data. The filtered OTU count table created through R(v3.5.0)29/DADA230 with tax-
onomy down to genera-level was used for the DESeq239 analysis. Normalised (x/ (sum (x)) OTU values from the 
same table were used for the PERMANOVA (adonis) test.
Shotgun metagenomic sequencing data. Values from the created count table (based on the estimated num-
ber of reads from bacterial genera calculated by MetaPhlAn v2.038) was used for the DESeq239 analysis. For 
the PERMANOVA (adonis) test, proportional abundances (calculated by MetaPhlAn v2.038) were used. Gene 
richness differences between methods (shotgun metagenomic sequencing data only) were assessed using the 
Wilcoxon signed-rank test.
Data Availability
The datasets generated and analysed during this study are derived from patients treated in Denmark. The datasets 
contain sensitive patient data governed by GDPR and Danish law. Due to Danish legislation (Act No. 502 of 23 
May 2018) and approvals granted by the Danish Data Protection Agency, it is not possible to upload raw data to 
a publicly available database. However, access to these data can be made available from the corresponding author 
on reasonable request, provided a data transfer agreement is entered into according to current regulations.
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